Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Judith, Feucht"'
Autor:
Jens Bauer, Natalie Köhler, Yacine Maringer, Philip Bucher, Tatjana Bilich, Melissa Zwick, Severin Dicks, Annika Nelde, Marissa Dubbelaar, Jonas Scheid, Marcel Wacker, Jonas S. Heitmann, Sarah Schroeder, Jonas Rieth, Monika Denk, Marion Richter, Reinhild Klein, Irina Bonzheim, Julia Luibrand, Ursula Holzer, Martin Ebinger, Ines B. Brecht, Michael Bitzer, Melanie Boerries, Judith Feucht, Helmut R. Salih, Hans-Georg Rammensee, Stephan Hailfinger, Juliane S. Walz
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-16 (2022)
The DNAJB1-PRKACA fusion transcript is the oncogenic driver in fibrolamellar hepatocellular carcinoma, a lethal disease with limited therapeutic options. Here, the authors identify the DNAJB1-PRKACA protein as a source for immunogenic neoepitopes and
Externí odkaz:
https://doaj.org/article/3a134c49c74b482cbf740f80cccba049
Autor:
Zeguo Zhao, Mohamad Hamieh, Justin Eyquem, Michel Sadelain, Maria Sjöstrand, Jorge Mansilla-Soto, Sascha Haubner, Judith Feucht, Noémie Paillon, Andres Zucchetti, Zhuoning Li, Pieter Lindenbergh, Michelle Saetersmoen, Mathieu Maurin, Archana Iyer, Anton Dobrin, Andreina Garcia Angus, Matthew Miele, Theodoros Giavridis, Sjoukje van der Stegen, Fella Tamzalit, Morgan Huse, Ronald Hendrickson, Claire Hivroz
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/595628448f684db780a076008ffd5232
Autor:
Semjon Willier, Karin Melanie Cabanillas Stanchi, Martina von Have, Vera Binder, Franziska Blaeschke, Judith Feucht, Tobias Feuchtinger, Michaela Döring
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Chemotherapy-induced nausea and vomiting (CINV) belong among the most burdensome side effects in hemato-oncology. Mostly, a combination of ondansetron and dexamethasone is used as antiemetic prophylaxis in pediatric patients under
Externí odkaz:
https://doaj.org/article/40dde7f3da78498c81cb29aeb9c1fa59
Autor:
Nayan Jain, Zeguo Zhao, Judith Feucht, Richard Koche, Archana Iyer, Anton Dobrin, Jorge Mansilla-Soto, Julie Yang, Yingqian Zhan, Michael Lopez, Gertrude Gunset, Michel Sadelain
Publikováno v:
Nature. 615:315-322
Autor:
Philip Bucher, Judith Feucht
Publikováno v:
Nature Cancer. 4:447-449
Autor:
Scott W. Lowe, Charles L. Sawyers, Cory Abate-Shen, Lukas E. Dow, John E. Wilkinson, Elisa de Stanchina, Philip A. Watson, Francisco J. Sánchez-Rivera, Nelson R. Salgado, Katarzyna Rybczyk, Sha Tian, Corina Amor, Amanda Kulick, Leah Zamechek, Kaloyan M. Tsanov, Francisco M. Barriga, Teng Han, Judith Feucht, Wassim Abida, Min Zou, Timour Baslan, Yu-Jui Ho, Zhen Cao, Marcus Ruscetti, Josef Leibold
Supplementary Figures and Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::198a864b097bc309e6ff0146b52c0bbb
https://doi.org/10.1158/2159-8290.22535048.v1
https://doi.org/10.1158/2159-8290.22535048.v1
Autor:
Scott W. Lowe, Charles L. Sawyers, Cory Abate-Shen, Lukas E. Dow, John E. Wilkinson, Elisa de Stanchina, Philip A. Watson, Francisco J. Sánchez-Rivera, Nelson R. Salgado, Katarzyna Rybczyk, Sha Tian, Corina Amor, Amanda Kulick, Leah Zamechek, Kaloyan M. Tsanov, Francisco M. Barriga, Teng Han, Judith Feucht, Wassim Abida, Min Zou, Timour Baslan, Yu-Jui Ho, Zhen Cao, Marcus Ruscetti, Josef Leibold
To study genetic factors influencing the progression and therapeutic responses of advanced prostate cancer, we developed a fast and flexible system that introduces genetic alterations relevant to human disease directly into the prostate glands of mic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31669b3f610693536fcf69ae0d284582
https://doi.org/10.1158/2159-8290.c.6547748.v1
https://doi.org/10.1158/2159-8290.c.6547748.v1
Autor:
Tanja A. Stief, Tobias Feuchtinger, Dirk H. Busch, Judith Feucht, Lena M. Jablonowski, Michaela Döring, Franziska Blaeschke, Kilian Schober, Semjon Willier, T. Müller, Rupert Handgretinger, Theresa Kaeuferle, Peter Lang, Kevin M. Dennehy
Publikováno v:
Mol Ther
Viral infections cause life-threatening disease in immunocompromised patients and especially following transplantation. T cell receptor (TCR) engineering redirects specificity and can bring significant progress to emerging adoptive T cell transfer (A
Autor:
Ashlesha Odak, Han Yuan, Judith Feucht, Vito Adrian Cantu, Jorge Mansilla-Soto, Friederike Kogel, Justin Eyquem, John K Everett, Frederic D. Bushman, Christina Leslie, Michel Sadelain
Publikováno v:
Blood.
Cell therapies that rely on engineered immune cells can be enhanced by achieving uniform and controlled transgene expression in order to maximize T cell function and achieve predictable patient responses. Although effective, current genetic engineeri
Autor:
SoniaJimenez Vazquez, DarjusFelix Tschaharganeh, Judith Feucht, Luise Butthof, Christos Patsis, Joan Crous-Masó, Hendrik Wiethoff, Rossella Pellegrino, Thomas Longerich, Matthias Gaida, Ilse Hofmann
Publikováno v:
39. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber.